Haemonetics Corporation (HAE)
USD 60.41
(2.13%)
USD 60.41
(2.13%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 2.19 Billion USD | 13.48% |
| 2023 | 1.93 Billion USD | 4.04% |
| 2022 | 1.85 Billion USD | 2.19% |
| 2021 | 1.81 Billion USD | 43.63% |
| 2020 | 1.26 Billion USD | -0.6% |
| 2019 | 1.27 Billion USD | 3.02% |
| 2018 | 1.23 Billion USD | -0.11% |
| 2017 | 1.23 Billion USD | -5.95% |
| 2016 | 1.31 Billion USD | -11.19% |
| 2015 | 1.48 Billion USD | -2.48% |
| 2014 | 1.52 Billion USD | 4.03% |
| 2013 | 1.46 Billion USD | 60.53% |
| 2012 | 910.63 Million USD | 9.28% |
| 2011 | 833.26 Million USD | 10.49% |
| 2010 | 754.14 Million USD | 16.08% |
| 2009 | 649.69 Million USD | 6.69% |
| 2008 | 608.95 Million USD | 6.32% |
| 2007 | 572.73 Million USD | 4.79% |
| 2006 | 546.54 Million USD | 16.84% |
| 2005 | 467.75 Million USD | 14.82% |
| 2004 | 407.39 Million USD | 13.41% |
| 2003 | 359.2 Million USD | -1.57% |
| 2002 | 364.92 Million USD | 5.68% |
| 2001 | 345.31 Million USD | -1.09% |
| 2000 | 349.11 Million USD | -2.05% |
| 1999 | 356.4 Million USD | 5.85% |
| 1998 | 336.7 Million USD | 4.08% |
| 1997 | 323.5 Million USD | 12.4% |
| 1996 | 287.8 Million USD | 2.6% |
| 1995 | 280.5 Million USD | 21.59% |
| 1994 | 230.7 Million USD | 27.95% |
| 1993 | 180.3 Million USD | 24.52% |
| 1992 | 144.8 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 2.19 Billion USD | 13.48% |
| 2024 Q2 | 2.01 Billion USD | 2.5% |
| 2024 Q1 | 1.96 Billion USD | 1.42% |
| 2024 Q3 | 2.2 Billion USD | 9.4% |
| 2024 Q4 | 2.19 Billion USD | -0.22% |
| 2023 Q4 | 1.93 Billion USD | 3.02% |
| 2023 Q2 | 1.86 Billion USD | 2.45% |
| 2023 Q3 | 1.87 Billion USD | 0.69% |
| 2023 Q1 | 1.82 Billion USD | -2.11% |
| 2023 FY | 1.93 Billion USD | 4.04% |
| 2022 Q4 | 1.85 Billion USD | 1.55% |
| 2022 Q2 | 1.8 Billion USD | 0.41% |
| 2022 Q1 | 1.79 Billion USD | -1.41% |
| 2022 FY | 1.85 Billion USD | 2.19% |
| 2022 Q3 | 1.83 Billion USD | 1.66% |
| 2021 FY | 1.81 Billion USD | 43.63% |
| 2021 Q1 | 1.43 Billion USD | 13.11% |
| 2021 Q2 | 1.41 Billion USD | -1.05% |
| 2021 Q3 | 1.31 Billion USD | -7.06% |
| 2021 Q4 | 1.81 Billion USD | 38.08% |
| 2020 Q3 | 1.23 Billion USD | 3.97% |
| 2020 Q2 | 1.19 Billion USD | -5.48% |
| 2020 Q1 | 1.25 Billion USD | -1.19% |
| 2020 FY | 1.26 Billion USD | -0.6% |
| 2020 Q4 | 1.26 Billion USD | 2.37% |
| 2019 Q4 | 1.27 Billion USD | 3.84% |
| 2019 Q2 | 1.26 Billion USD | 1.98% |
| 2019 FY | 1.27 Billion USD | 3.02% |
| 2019 Q1 | 1.24 Billion USD | 0.31% |
| 2019 Q3 | 1.22 Billion USD | -3.01% |
| 2018 Q4 | 1.23 Billion USD | -5.67% |
| 2018 Q1 | 1.25 Billion USD | 1.02% |
| 2018 FY | 1.23 Billion USD | -0.11% |
| 2018 Q2 | 1.27 Billion USD | 1.58% |
| 2018 Q3 | 1.31 Billion USD | 3.19% |
| 2017 Q1 | 1.31 Billion USD | 0.02% |
| 2017 Q3 | 1.3 Billion USD | -2.13% |
| 2017 Q2 | 1.33 Billion USD | 1.32% |
| 2017 Q4 | 1.23 Billion USD | -5.18% |
| 2017 FY | 1.23 Billion USD | -5.95% |
| 2016 Q2 | 1.41 Billion USD | -0.59% |
| 2016 Q1 | 1.42 Billion USD | -3.76% |
| 2016 Q3 | 1.33 Billion USD | -5.82% |
| 2016 Q4 | 1.31 Billion USD | -1.45% |
| 2016 FY | 1.31 Billion USD | -11.19% |
| 2015 Q4 | 1.48 Billion USD | 0.77% |
| 2015 Q1 | 1.47 Billion USD | -2.9% |
| 2015 Q2 | 1.47 Billion USD | -0.15% |
| 2015 Q3 | 1.47 Billion USD | -0.19% |
| 2015 FY | 1.48 Billion USD | -2.48% |
| 2014 FY | 1.52 Billion USD | 4.03% |
| 2014 Q4 | 1.52 Billion USD | 2.06% |
| 2014 Q3 | 1.49 Billion USD | 0.44% |
| 2014 Q2 | 1.48 Billion USD | 0.27% |
| 2014 Q1 | 1.47 Billion USD | 1.21% |
| 2013 Q3 | 1.47 Billion USD | 1.36% |
| 2013 FY | 1.46 Billion USD | 60.53% |
| 2013 Q4 | 1.46 Billion USD | -0.85% |
| 2013 Q1 | 928.12 Million USD | 1.86% |
| 2013 Q2 | 1.45 Billion USD | 56.72% |
| 2012 Q3 | 847.77 Million USD | 2.92% |
| 2012 FY | 910.63 Million USD | 9.28% |
| 2012 Q2 | 823.72 Million USD | -3.48% |
| 2012 Q1 | 853.4 Million USD | 2.42% |
| 2012 Q4 | 911.13 Million USD | 7.47% |
| 2011 Q3 | 783.38 Million USD | 6.19% |
| 2011 Q1 | 694.16 Million USD | -8.74% |
| 2011 FY | 833.26 Million USD | 10.49% |
| 2011 Q4 | 833.26 Million USD | 6.37% |
| 2011 Q2 | 737.73 Million USD | 6.28% |
| 2010 FY | 754.14 Million USD | 16.08% |
| 2010 Q4 | 760.66 Million USD | 8.32% |
| 2010 Q3 | 702.21 Million USD | -1.69% |
| 2010 Q2 | 714.29 Million USD | 3.23% |
| 2010 Q1 | 691.94 Million USD | 6.5% |
| 2009 Q4 | 649.69 Million USD | 4.39% |
| 2009 FY | 649.69 Million USD | 6.69% |
| 2009 Q3 | 622.34 Million USD | 3.6% |
| 2009 Q1 | 608.22 Million USD | -0.12% |
| 2009 Q2 | 600.71 Million USD | -1.24% |
| 2008 Q4 | 608.95 Million USD | 7.68% |
| 2008 FY | 608.95 Million USD | 6.32% |
| 2008 Q1 | 578.1 Million USD | 0.94% |
| 2008 Q2 | 548.69 Million USD | -5.09% |
| 2008 Q3 | 565.53 Million USD | 3.07% |
| 2007 Q1 | 568.23 Million USD | 3.97% |
| 2007 Q3 | 549.86 Million USD | -2.06% |
| 2007 FY | 572.73 Million USD | 4.79% |
| 2007 Q4 | 572.73 Million USD | 4.16% |
| 2007 Q2 | 561.43 Million USD | -1.2% |
| 2006 Q3 | 523.13 Million USD | 4.79% |
| 2006 FY | 546.54 Million USD | 16.84% |
| 2006 Q2 | 499.22 Million USD | 2.75% |
| 2006 Q1 | 485.86 Million USD | 3.87% |
| 2006 Q4 | 546.54 Million USD | 4.47% |
| 2005 FY | 467.75 Million USD | 14.82% |
| 2005 Q4 | 467.75 Million USD | 2.4% |
| 2005 Q1 | 416.38 Million USD | 2.21% |
| 2005 Q2 | 427.53 Million USD | 2.68% |
| 2005 Q3 | 456.77 Million USD | 6.84% |
| 2004 Q2 | 374.38 Million USD | 2.24% |
| 2004 FY | 407.39 Million USD | 13.41% |
| 2004 Q3 | 396.56 Million USD | 5.92% |
| 2004 Q4 | 407.39 Million USD | 2.73% |
| 2004 Q1 | 366.18 Million USD | 1.94% |
| 2003 Q1 | 355.07 Million USD | -2.7% |
| 2003 Q3 | 365.92 Million USD | 2.82% |
| 2003 Q2 | 355.88 Million USD | 0.23% |
| 2003 FY | 359.2 Million USD | -1.57% |
| 2003 Q4 | 359.2 Million USD | -1.83% |
| 2002 Q2 | 392.01 Million USD | 6.05% |
| 2002 Q3 | 389 Million USD | -0.77% |
| 2002 Q1 | 369.64 Million USD | 7.05% |
| 2002 Q4 | 364.92 Million USD | -6.19% |
| 2002 FY | 364.92 Million USD | 5.68% |
| 2001 Q2 | 323.13 Million USD | -4.37% |
| 2001 Q1 | 337.91 Million USD | -3.21% |
| 2001 Q3 | 342.44 Million USD | 5.97% |
| 2001 FY | 345.31 Million USD | -1.09% |
| 2001 Q4 | 345.31 Million USD | 0.84% |
| 2000 Q4 | 349.11 Million USD | -3.53% |
| 2000 Q2 | 347.4 Million USD | 1.64% |
| 2000 Q3 | 361.9 Million USD | 4.17% |
| 2000 Q1 | 341.8 Million USD | -4.1% |
| 2000 FY | 349.11 Million USD | -2.05% |
| 1999 Q4 | 356.4 Million USD | 0.91% |
| 1999 Q1 | 331.4 Million USD | -1.57% |
| 1999 Q2 | 342.7 Million USD | 3.41% |
| 1999 Q3 | 353.2 Million USD | 3.06% |
| 1999 FY | 356.4 Million USD | 5.85% |
| 1998 FY | 336.7 Million USD | 4.08% |
| 1998 Q2 | 366.9 Million USD | 5.55% |
| 1998 Q3 | 359.4 Million USD | -2.04% |
| 1998 Q4 | 336.7 Million USD | -6.32% |
| 1998 Q1 | 347.6 Million USD | 7.45% |
| 1997 FY | 323.5 Million USD | 12.4% |
| 1997 Q4 | 323.5 Million USD | 3.72% |
| 1997 Q1 | 296.2 Million USD | 2.92% |
| 1997 Q2 | 308.8 Million USD | 4.25% |
| 1997 Q3 | 311.9 Million USD | 1.0% |
| 1996 FY | 287.8 Million USD | 2.6% |
| 1996 Q2 | 289.8 Million USD | 2.08% |
| 1996 Q1 | 283.9 Million USD | 1.21% |
| 1996 Q4 | 287.8 Million USD | -0.21% |
| 1996 Q3 | 288.4 Million USD | -0.48% |
| 1995 FY | 280.5 Million USD | 21.59% |
| 1995 Q4 | 280.5 Million USD | 7.55% |
| 1995 Q1 | 235.7 Million USD | 2.17% |
| 1995 Q3 | 260.8 Million USD | 3.37% |
| 1995 Q2 | 252.3 Million USD | 7.04% |
| 1994 FY | 230.7 Million USD | 27.95% |
| 1994 Q2 | 201.1 Million USD | 8.94% |
| 1994 Q3 | 207.1 Million USD | 2.98% |
| 1994 Q4 | 230.7 Million USD | 11.4% |
| 1994 Q1 | 184.6 Million USD | 2.38% |
| 1993 Q3 | 162.2 Million USD | 0.93% |
| 1993 Q2 | 160.7 Million USD | 5.58% |
| 1993 Q4 | 180.3 Million USD | 11.16% |
| 1993 Q1 | 152.2 Million USD | 5.11% |
| 1993 FY | 180.3 Million USD | 24.52% |
| 1992 Q3 | 144.3 Million USD | 10.57% |
| 1992 FY | 144.8 Million USD | 0.0% |
| 1992 Q4 | 144.8 Million USD | 0.35% |
| 1992 Q1 | 119.7 Million USD | 0.0% |
| 1992 Q2 | 130.5 Million USD | 9.02% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alcon Inc. | 29.6 Billion USD | 92.583% |
| AptarGroup, Inc. | 4.45 Billion USD | 50.682% |
| Baxter International Inc. | 28.27 Billion USD | 92.235% |
| Becton, Dickinson and Company | 52.78 Billion USD | 95.84% |
| Bausch + Lomb Corporation | 13.44 Billion USD | 83.666% |
| Envista Holdings Corp | 6.6 Billion USD | 66.759% |
| ResMed Inc. | 6.87 Billion USD | 68.052% |
| Teleflex Incorporated | 7.53 Billion USD | 70.852% |
| Warby Parker Inc. | 580.31 Million USD | -278.347% |
| West Pharmaceutical Services, Inc. | 3.82 Billion USD | 42.666% |